Harvey Capital Management Inc Bristol Myers Squibb CO Transaction History

Harvey Capital Management Inc

$341 Million
Q1 2024

A detailed history of Harvey Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Harvey Capital Management Inc holds 29,010 shares of BMY stock, worth $1.2 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

29,010

Previous 29,184 0.6%

Holding current value

$1.2 Million

Previous $1.5 Million 5.08%

% of portfolio

0.46%

Previous 0.5%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $8,348 - $9,465	-174 Reduced 0.6%	29,010 $1.57 Million
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $1.31 Million - $1.56 Million	-27,000 Reduced 48.06%	29,184 $1.5 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $8,683 - $9,709	-150 Reduced 0.27%	56,184 $3.26 Million
Q1 2023 May 17, 2023	BUY	$65.71 - $74.53 $3.7 Million - $4.2 Million	56,334 New	56,334 $3.9 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $10.6 Million - $11.6 Million	-145,641 Closed	0 $0

Q1 2022 Apr 22, 2022	SELL	$61.48 - $73.72 $756,511 - $907,124	-12,305 Reduced 7.79%	145,641 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $545,953 - $636,453	10,180 Added 6.89%	157,946 $9.85 Million
Q3 2021 Oct 25, 2021	BUY	$59.17 - $69.31 $40,827 - $47,823	690 Added 0.47%	147,766 $8.74 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $116,081 - $126,412	-1,875 Reduced 1.26%	147,076 $9.83 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $222,821 - $250,608	3,755 Added 2.59%	148,951 $9.4 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $640,914 - $726,273	-11,100 Reduced 7.1%	145,196 $9.01 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $674,113 - $747,006	-11,738 Reduced 6.99%	156,296 $9.42 Million
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $270,701 - $316,476	4,938 Added 3.03%	168,034 $9.88 Million
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $153,120 - $222,519	-3,300 Reduced 1.98%	163,096 $9.09 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $3.03 Million - $3.95 Million	61,596 Added 58.77%	166,396 $10.7 Million
Q3 2019 Oct 17, 2019	SELL	$42.77 - $50.71 $34,216 - $40,568	-800 Reduced 0.76%	104,800 $5.31 Million
Q2 2019 Jul 23, 2019	BUY	$44.62 - $49.34 $4.52 Million - $5 Million	101,300 Added 2355.81%	105,600 $4.79 Million
Q1 2019 Apr 17, 2019	BUY	$45.12 - $53.8 $194,016 - $231,340	4,300 New	4,300 $205,000

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Capital Management Inc with notifications on news.

Account

Harvey Capital Management Inc Bristol Myers Squibb CO Transaction History